Skip to main navigation
Skip to search
Skip to main content
University Medical Center Utrecht Home
Help & FAQ
Home
Profiles
Research units
Research output
Activities
Prizes
Press/Media
Search by expertise, name or affiliation
Chemoradiatie bij het spierinvasieve blaascarcinoom
Translated title of the contribution
:
Chemoradiation for muscle invasive bladder cancer
Richard P. Meijer
*
*
Corresponding author for this work
Department of Urology
Department of Urological Oncology
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemoradiation for muscle invasive bladder cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
100%
Muscle Invasive Bladder Cancer
100%
Neoplasm
50%
Recurrent Disease
50%
Chemotherapy
50%
Recurrence Free Survival
50%
Gastrointestinal Toxicity
50%
Medicine and Dentistry
Gastrointestinal Toxicity
50%
Bladder Function
50%